# Race And CPAP Effectiveness

Study · id `cardio:ct-nct01960465` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01960465](<https://clinicaltrials.gov/study/NCT01960465>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01960465

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 220 participants.

## Technical summary

Registry record NCT01960465. Non-randomized; single masking; primary purpose treatment. Start 2015-01-05 (actual); primary completion 2019-08-30 (actual). Results posted on 2020-11-20.

## Key facts

- Design: Interventional study; non-randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 220 participants (enrolled count; ClinicalTrials.gov record NCT01960465, source copy `cardio:ctgov-nct01960465-2020-11-20`, retrieved 2026-10-26)
- Started: 2015-01-05 (actual) (ClinicalTrials.gov record NCT01960465, source copy `cardio:ctgov-nct01960465-2020-11-20`, retrieved 2026-10-26)
- Primary completion: 2019-08-30 (actual) (ClinicalTrials.gov record NCT01960465, source copy `cardio:ctgov-nct01960465-2020-11-20`, retrieved 2026-10-26)
- Completion: 2019-08-30 (actual) (ClinicalTrials.gov record NCT01960465, source copy `cardio:ctgov-nct01960465-2020-11-20`, retrieved 2026-10-26)
- Results first posted: 2020-11-20 (ClinicalTrials.gov record NCT01960465, source copy `cardio:ctgov-nct01960465-2020-11-20`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT01960465, source copy `cardio:ctgov-nct01960465-2020-11-20`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01960465-2020-11-20`, retrieved 2026-10-26)

## The registry's words

- Brief title: Race And CPAP Effectiveness
- Acronym: RACE
- Condition: Sleep Apnea Syndromes
- Intervention (Device): Continuous positive airway pressure
- Lead sponsor: VA Office of Research and Development
- Lead sponsor class: FED

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry lists this organization as the lead sponsor: VA Office of Research and Development (`cardio:org-va-office-of-research-and-development`)

## Provenance

Content hash: 050029c51af68149a0ecc54b04ecd11a90ef037e6bae96ba2b300b3c3d2e3cbc
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
